Cytarabine release from α,β-poly(N-hydroxyethyl)-DL-aspartamide matrices cross-linked through γ-radiation

Biomaterials

Volumn 17, Issue 10, 1996, Pages 953-958

  Spadaro, Giuseppe ^a   Dispenza, Clelia ^a   Giammona, Gaetano ^a   Pitarresi, Giovanna ^a   Cavallaro, Gennara ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Controlled release; Cytarabine; Drug delivery; , poly(N hydroxyethyl) dl aspartamide

Indexed keywords

CHARACTERIZATION; CROSSLINKING; DRUG PRODUCTS; DRUG THERAPY; GAMMA RAYS; MOLECULES; ORGANIC POLYMERS; RADIATION; SCANNING ELECTRON MICROSCOPY; X RAY ANALYSIS;

BIOACTIVE MOLECULES; CYTARABINE; DRUG DELIVERY SYSTEMS; IN VITRO RELEASE BEHAVIOR; SYNTHETIC POLYMER; WATER SWELLING MEASUREMENTS;

BIOMATERIALS;

ALPHA,BETA POLY(N HYDROXYETHYL) DL ASPARTAMIDE; ANTINEOPLASTIC AGENT; CYTARABINE; POLYMER; UNCLASSIFIED DRUG; WATER;

ARTICLE; CROSS LINKING; DRUG RELEASE; GAMMA IRRADIATION; MEASUREMENT; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUSTAINED RELEASE PREPARATION; X RAY ANALYSIS;

CHEMISTRY, PHARMACEUTICAL; CROSS-LINKING REAGENTS; CYTARABINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GAMMA RAYS; KINETICS; MICROSCOPY, ELECTRON, SCANNING; PEPTIDES; SOLUTIONS; X-RAY DIFFRACTION;

EID: 0030152583     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/0142-9612(96)84668-0     Document Type: Article

References (30)

1. Trouet A, Schneider YJ. In: Buri P, Gumma A, eds. Drug Targeting: A Long Way from Concept to Clinical Applications. Amsterdam: Elsevier Science, 1985: 1-12.
2. Rihova B, Kopacek J. In: Anderson JM, Kim SW eds. Advances in Drug Delivery Systems. Amsterdam: Elsevier Science, 1986: 289-310
3. Van Heeswijk WAR, Hoes CJT, Stoffer T, Eenink MJD, Potman W, Feijen J. The synthesis and characterization of polypeptide-adriamycin conjugates and its complexes with adriamycin. Part I. J Contr Rel 1985; 1: 301-315.
4. Gambotz WR, Hoffman AS. In: Peppas NA, ed. Hydrogels in Medicine and Pharmacy, Vol. 1 Fundamentals, Chap. 5. Boca Raton, FL: CRC Press, 1986: 95-126.
5. Bos E., Boon P., Kaspersen F, McCabe R. Passive immunotherapy of cancer: perspectives and problems. J Contr Rel 1991; 16: 101-111.
6. Duncan R, Hum IC, Vardley HJ et al. Macromolecular prodrugs for use in targeted cancer chemotherapy: melphalan covalently coupled to N-(2-hydroxypropyl)methacrylamide copolymers. J Contr Rel 1991; 16: 121-136.
7. Pallavicini MG. Cytosine arabinoside: molecular, pharmacokinetic and cytokinetic considerations. Pharmacol Ther 1984; 25: 207-238.
8. 4-behenoyl-1-β-D-arabinofuranosylcytosine (BH-AC) and 2,2′-anhydro-1-β-D-arabinofuranosylcytosine (cyclo-C) against human cytomegalovirus. J Med Virol 1990; 31: 141-147.
9. Vonda V, Anisimova E, Cerny J, Holy A, Rosenberg I, Votruba I. Properties of a 9-(2-phosphonyl methoxyethyl)adenine (PMEA)-resistant herpes simplex virus type 1 virus mutant. Antiviral Res 1990; 14: 117-121.
10. Vilpo JA, Veromaa T, Eerola E. Effect of cytosine arabinoside on the human immunosystem: metabolism and cytotoxicity studied with mitogen-stimulated normal blood lymphocytes in vitro. Int J Immunopharmacol 1988; 10: 593-600.
11. Shrivastava RS, Ratinaud MH, Julien R. Differential toxicity of cytosine arabinoside to cell kinetics in normal sheep sinus cells and sheep tumor cell line in vitro. Toxicolin Vitro 1990; 4: 143-147.
12. DeLoach JR, Barton C. Circulating carrier erythrocytes: slow-release vehicle for an antileukemic drug, cytosine arabinoside. Am J Vet Res 1982; 43: 2210-2212.
13. Tsukada K, Ueda S, Okada R. Preparation of liposome-encapsulated antitumor drugs; relationship between lipophilicity of drugs and in vitro drug release. Chem Pharm Bull 1984; 32: 1929-1935.
14. Cho CS, Park JW, Kwon JK et al. Release of cytarabine from biodegradable poly(γ-benzyl-L-glutamate) block copolymer microsphere. Pollimo 1991; 15: 27-33.
15. 4-(4-carboxybutyryl)-ara-C and ethylenediamine-introduced dextran. Drug release profiles and further in vivo study of its antitumor effects. Drug Des Delivery 1991; 7: 139-145.
16. Neri P, Antoni G, Benvenuti F, Cocola F, Gazzei G. Synthesis of α,β-poly[(2-hydroxyethyl)-DL-aspartamide], a new plasma expander. J Med Chem 1973; 16: 893-897.
17. Antoni G, Arezzini C, Cocola F, Gazzei G, Neri P. Pharmacological and toxicological evaluation of polyhydroxyethylaspartamide (PHEA) as a plasma substitute. Il Farmaco Ed Pr 1979; 34: 146-156.
18. Drobnik J, Saudek V, Vlasak J, Kalal J. Polyaspartamide. A potential drug carrier. J Polym Symp 1979; 66: 65-74.
19. Okada M, Matsushima A, Katsuhaya A, Aoyama T, Ando T, Inoda Y. Suppression of IgE antibody response against ovoalbumin by the chemical conjugate of ovoalumin with a polyaspartic acid derivative. Int Archs Allergy Appl Immun 1985; 76: 79-81.
20. Giammona G, Carlisi B, Palazzo S. Reaction of α,β-poly(N-hydroxyethyl)-DL-aspartamide with derivatives of carboxylic acids. J Polym Sci Polym Chem Edn 1987; 25:2813-2818.
21. Giammona G, Carlisi B, Cavallaro G, Pitarresi G, Palazzo S. Anticancer agent coupled to polyaspartamide as a drug carrier. Eur J Pharm Biopharm 1992; 38: 159-162.
22. Giammona G, Carlisi B, Pitarresi G, Cavallaro G, Turco Liveri V. Water-soluble copolymers of an antiviral agent: synthesis and their interaction with a biomembrane model. J Contr Rel 1992; 22: 197-204.
23. Giammona G, Cavallaro G, Pitarresi G, Ventura C, Palazzo S. Synthesis and therapeutic potential of a macromolecular prodrug of diflunisal. Int J Pharm 1994; 105: 57-63.
24. Calderaro E, Oliveri E, Tallarita P. Quaderni dell' Istituto di Applicazioni d Impianti Nucleari, Vol. 3. University of Palermo, 1980.
25. Robert CCR, Buri PA, Peppas NA. Influence of the drug solubility and dissolution medium on the release from poly(2-hydroxyethyl methacrylate) microspheres. J Contr Rel 1987; 5: 151-157.
26. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983; 15: 25-35.
27. Sinclair GW, Peppas NA. Analysis of non-Fickian transport in polymer using simplified exponential expressions. J Membr Sci 1984; 17: 329-331.
28. Ritger PL, Peppas NA. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Contr Rel 1987; 5: 37-42.
29. Peppas NA, Sahlin JJ. A simple equation for the description of solute release. II. Coupling of diffusion and relaxation. Int J Pharm 1989; 57: 169-172.
30. Baker RW, Lonsdale HK. In: Tanquary AS, Lacey RE, eds. Controlled Release: Mechanism and Rates. Controlled Release of Biologically Active Agents. New York: Plenum Press, 1974: 15-71.